PTG‐Dependent Glycogen Metabolic Dysfunction Drives Impaired Adipose Browning: A Novel Mechanism Linking PM 2.5 to Metabolic Disorders
Source abstract
Abstract
ABSTRACT Fine particulate matter (PM 2.5 ) contributes to metabolic dysfunction, but its effects on adipose tissue browning remain unclear. Here, we showed that PM 2.5 exposure inhibited inguinal white adipose tissue (iWAT) browning by downregulating protein targeting to glycogen (PTG), disrupting glycogen homeostasis. PTG overexpression in iWAT restored glycogen metabolism, thermogenesis, and mitochondrial function, reversing PM 2.5 ‐induced impairment in iWAT browning and metabolic disorders. Mechanistically, PTG negatively regulated vascular endothelial growth factor B (VEGFB), and VEGFB knockdown rescued browning. Activation of β3‐adrenergic receptor (ADRB3) mitigated PM 2.5 ’s effects by restoring PTG and normalizing VEGFB, defining the ADRB3‐PTG‐VEGFB axis as central to PM 2.5 ‐induced metabolic dysfunction. Our findings identify adipose glycogen metabolism as a target for countering environmental metabolic disruption.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Adipose Tissue and Metabolism · Adipokines, Inflammation, and Metabolic Diseases · Cardiovascular Disease and Adiposity
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Public Health Zhejiang Chinese Medical University Hangzhou Zhejiang China
Zhejiang International Science and Technology Cooperation Base of Air Pollution and Health Hangzhou Zhejiang China
Academy of Chinese Medical Sciences Zhejiang Chinese Medical University Hangzhou Zhejiang China
Funding
National Natural Science Foundation of China
References (66)
Show source-provided references
1. 10.1016/j.envint.2015.10.01610.1016/j.envint.2015.10.016 ↗
2. 10.1016/j.jacc.2019.12.03110.1016/j.jacc.2019.12.031 ↗
3. 10.1146/annurev‐med‐042220‐01154910.1146/annurev‐med‐042220‐011549 ↗
4. 10.1016/j.jhazmat.2024.13465910.1016/j.jhazmat.2024.134659 ↗
5. 10.1186/s12989‐014‐0053‐510.1186/s12989‐014‐0053‐5 ↗
6. 10.1016/j.envint.2020.10595010.1016/j.envint.2020.105950 ↗
7. 10.1289/EHP794410.1289/EHP7944 ↗
8. 10.1186/s12989‐017‐0187‐310.1186/s12989‐017‐0187‐3 ↗
9. 10.2337/dc23‐215310.2337/dc23‐2153 ↗
10. 10.1289/EHP968810.1289/EHP9688 ↗
11. 10.1289/ehp.130684110.1289/ehp.1306841 ↗
12. 10.1021/acs.est.2c0156810.1021/acs.est.2c01568 ↗
13. 10.1007/s00394‐018‐1790‐210.1007/s00394‐018‐1790‐2 ↗
14. 10.1038/nrendo.2013.20410.1038/nrendo.2013.204 ↗
15. 10.1038/nrm.2016.9610.1038/nrm.2016.96 ↗
16. 10.1038/srep1797710.1038/srep17977 ↗
17. 10.1016/j.cmet.2024.05.00510.1016/j.cmet.2024.05.005 ↗
18. 10.1038/s41467‐023‐43418‐510.1038/s41467‐023‐43418‐5 ↗
19. 10.1016/j.heliyon.2024.e2893610.1016/j.heliyon.2024.e28936 ↗
20. 10.1016/j.nantod.2024.10216710.1016/j.nantod.2024.102167 ↗
21. 10.1126/sciadv.aau604410.1126/sciadv.aau6044 ↗
22. 10.1016/j.carbpol.2019.11552610.1016/j.carbpol.2019.115526 ↗
23. 10.1111/jpi.1282310.1111/jpi.12823 ↗
24. 10.3390/ijerph1407078710.3390/ijerph14070787 ↗
25. 10.1016/0003‐9861(64)90374‐110.1016/0003‐9861(64)90374‐1 ↗
26. 10.1126/science.275.5305.147510.1126/science.275.5305.1475 ↗
27. 10.1016/j.ibror.2016.10.00210.1016/j.ibror.2016.10.002 ↗
28. 10.1038/s41586‐021‐04019‐810.1038/s41586‐021‐04019‐8 ↗
29. 10.3390/ijms2117624110.3390/ijms21176241 ↗
30. 10.1038/s41467‐019‐12988‐810.1038/s41467‐019‐12988‐8 ↗
31. 10.1152/ajpendo.00741.200910.1152/ajpendo.00741.2009 ↗
32. 10.1016/j.envpol.2023.12134710.1016/j.envpol.2023.121347 ↗
33. 10.1186/s12989‐020‐00356‐010.1186/s12989‐020‐00356‐0 ↗
34. 10.1186/s12986‐022‐00694‐010.1186/s12986‐022‐00694‐0 ↗
35. 10.1152/ajpendo.00600.200910.1152/ajpendo.00600.2009 ↗
36. 10.1038/s41598‐018‐33438‐310.1038/s41598‐018‐33438‐3 ↗
37. 10.1016/j.cmet.2020.11.00810.1016/j.cmet.2020.11.008 ↗
38. 10.1016/j.carbpol.2024.12263110.1016/j.carbpol.2024.122631 ↗
39. 10.1042/BJ2011141610.1042/BJ20111416 ↗
40. 10.1073/pnas.080562110510.1073/pnas.0805621105 ↗
41. 10.1172/JCI13731510.1172/JCI137315 ↗
42. 10.1038/nrendo.2017.8010.1038/nrendo.2017.80 ↗
43. 10.1038/s41467‐022‐33693‐z10.1038/s41467‐022‐33693‐z ↗
44. 10.3390/biom1212175510.3390/biom12121755 ↗
45. 10.1016/j.molmet.2015.10.00110.1016/j.molmet.2015.10.001 ↗
46. 10.1161/CIRCULATIONAHA.120.05063510.1161/CIRCULATIONAHA.120.050635 ↗
47. 10.1016/j.cmet.2016.03.01210.1016/j.cmet.2016.03.012 ↗
48. 10.1172/JCI17658610.1172/JCI176586 ↗
49. 10.1055/s‐2007‐100126010.1055/s‐2007‐1001260 ↗
50. Clinical Association of Circulating VEGF‐B Levels with Hyperlipidemia and Target Organ Damage in Type 2 Diabetic Patients
51. 10.3390/ijms2314752410.3390/ijms23147524 ↗
52. 10.1161/CIRCRESAHA.124.32518710.1161/CIRCRESAHA.124.325187 ↗
53. 10.1016/j.preteyeres.2021.10095410.1016/j.preteyeres.2021.100954 ↗
54. 10.3389/fcvm.2018.0003910.3389/fcvm.2018.00039 ↗
55. 10.1038/nm0603‐66910.1038/nm0603‐669 ↗
56. 10.1084/jem.2017101210.1084/jem.20171012 ↗
57. 10.3390/ijms2409836210.3390/ijms24098362 ↗
58. 10.1038/s42255‐022‐00667‐w10.1038/s42255‐022‐00667‐w ↗
59. 10.1038/s41420‐022‐00818‐810.1038/s41420‐022‐00818‐8 ↗
60. 10.1172/jci.insight.13916010.1172/jci.insight.139160 ↗
61. 10.1002/ptr.745110.1002/ptr.7451 ↗
62. 10.1080/0895837059091274310.1080/08958370590912743 ↗
63. 10.1289/ehp.9510317210.1289/ehp.95103172 ↗
64. 10.1038/s42255‐021‐00520‐610.1038/s42255‐021‐00520‐6 ↗
65. 10.1016/j.cell.2022.02.00410.1016/j.cell.2022.02.004 ↗
66. 10.1289/EHP1164610.1289/EHP11646 ↗